Kai Xian Chen
Directeur/Membre du Conseil chez JIANGSU KANION PHARMACEUTICAL CO.,LTD.
Fortune : 811 926 $ au 30/04/2024
Profil
Kai Xian Chen is currently the Chairman of the Chinese Association of Integrative Medicine, Vice Chairman of the Shanghai Overseas Returned Scholars Association, Chairman of the Shanghai Pudong Association For Science & Technology, Independent Director at Jiangsu Kanion Pharmaceutical Co., Ltd., Independent Non-Executive Director at Innovent Biologics, Inc., Independent Director at Zai Lab Ltd., Independent Non-Executive Director at InnoCare Pharma Ltd., Adjunct Professor at Fudan University, President at the University of Shanghai for Science & Technology, and Adjunct Professor at China Pharmaceutical University.
He previously served as the Chairman of the Shanghai Association for Science & Technology, Vice Chairman-Council of the China Pharmaceuticals Association, Independent Non-Executive Director of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd., Independent Non-Executive Director of Fosun International Ltd., Independent Director of Jiangsu Hengrui Pharmaceuticals Co., Ltd., Member of the Chinese Academy of Sciences, and Deputy President of the Chinese Pharmaceutical Association.
He has also held positions as a Professor at the Shanghai Institute of Materia Medica Chinese Academy of Sci and the Shanghai University of Traditional Chinese Medicine.
Dr. Chen received his undergraduate degree from Fudan University and his graduate and doctorate degrees from the Shanghai Institute of Materia Medica Chinese Academy of Sci.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ZAI LAB LTD.
0,05% | 12/04/2024 | 472 750 ( 0,05% ) | 785 781 $ | 30/04/2024 |
INNOVENT BIOLOGICS, INC.
0,00% | 22/03/2024 | 5 346 ( 0,00% ) | 26 145 $ | 30/04/2024 |
Postes actifs de Kai Xian Chen
Sociétés | Poste | Début |
---|---|---|
INNOVENT BIOLOGICS, INC. | Directeur/Membre du Conseil | 18/10/2018 |
ZAI LAB LIMITED | Directeur/Membre du Conseil | 14/08/2018 |
INNOCARE PHARMA LIMITED | Directeur/Membre du Conseil | 01/03/2020 |
JIANGSU KANION PHARMACEUTICAL CO.,LTD. | Directeur/Membre du Conseil | 27/12/2019 |
China Pharmaceutical University | Corporate Officer/Principal | - |
Chinese Pharmacopoeia Commission | Corporate Officer/Principal | 01/01/2017 |
Shanghai Pudong Association For Science & Technology | Président | - |
Fudan University | Corporate Officer/Principal | - |
Chinese Association of Integrative Medicine | Président | - |
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Kai Xian Chen
Sociétés | Poste | Fin |
---|---|---|
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kai Xian Chen
Shanghai Institute of Materia Medica Chinese Academy of Sci | Doctorate Degree |
Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 7 |
---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
FOSUN INTERNATIONAL LIMITED | Finance |
INNOVENT BIOLOGICS, INC. | Health Technology |
ZAI LAB LIMITED | Health Technology |
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. | Health Technology |
INNOCARE PHARMA LIMITED | Health Technology |
JIANGSU KANION PHARMACEUTICAL CO.,LTD. | Health Technology |
Entreprise privées | 7 |
---|---|
China Pharmaceuticals Association | |
Shanghai Association for Science & Technology | |
Shanghai Overseas Returned Scholars Association | |
Chinese Association of Integrative Medicine | |
Shanghai Pudong Association For Science & Technology | |
Chinese Pharmacopoeia Commission | |
Chinese Pharmaceutical Association |